Pertussis infection in adults

Southern Medical Journal

Volumn 91, Issue 8, 1998, Pages 702-709

  Wright, Seth W ^a,b  

^a Vanderbilt University ^*

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIBODY; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; HEMAGGLUTININ; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACKACHE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENCEPHALITIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNITY; IMMUNIZATION; INCIDENCE; NONHUMAN; PERTUSSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; REVIEW; RIB FRACTURE; SEROLOGY;

EID: 0031829275     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199808000-00001     Document Type: Review

References (48)

1. Cherry JD, Baraff LJ, Hewlett E: The past, present, and future of pertussis: the role of adults in epidemiology and future control. West J Med 1989; 150:319-328
2. Olson LC: Pertussis. Medicine 1975; 54:427-469
3. Gordon JE, Hood HI: Whooping cough and its epidemiological anomalies. Am J Med Sci 1951; 222:333-361
4. Centers for Disease Control and Prevention: Pertussis surveillance-United States, 1989-1991. MMWR 1992; 41:11-19
5. Mannerstedt G: Pertussis in adults. J Pediatr 1934; 5:596-600
6. Phillips J: Whooping cough contracted at the time of birth, with report of two cases. Am J Med Sci 1921; 161:163-165
7. Linneman CC, Nasenbeny J: Pertussis in the adult. Ann Rev Med 1977; 28:179-185
8. Lambert HJ: Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 1965; 80:365-369
9. Morse SI: Pertussis in adults. Ann Intern Med 1968; 68:953-954
10. Bordet J, Gengou O: Le microbe de la coqueluche. Ann Inst Pasteur (Paris) 1906; 20:731-741
11. Rich AR: On the etiology and pathogenesis of whooping cough. Bull Johns Hopkins Hosp 1932; 51:346-359
12. Macdonald H, Macdonald EJ: Experimental pertussis. J Infect Dis 1933; 53:328-330
13. Granstrom M, Askelof P: Parapertussis: an abortive pertussis infection. Lancet 1982; 2:1249-1250
14. Edwards KM, Karzon DT: Pertussis vaccines. Pediatr Clin North Am 1990; 37:549-566
15. Centers for Disease Control and Prevention: Summary of notifiable diseases, United States, 1995. MMWR 1996; 44:74-75
16. Sutter RW, Cochi SL: Pertussis hospitalizations and mortality in the United States, 1985-1988: evaluation of the completeness of national reporting. JAMA 1992; 267:386-391
17. Centers for Disease Control and Prevention: Resurgence of pertussis-United States, 1993. MMWR 1993; 42:952-953, 959-960
18. Robertson PW, Goldberg H, Jarvie BH, et al: Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987; 146:522-525
19. Mink CM, Cherry JD, Christenson P, et al: A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464-471
20. Wright SW, Edwards KM, Decker MD, et al: Pertussis infection in adults with a persistent cough. JAMA 1995; 273:1044-1046
21. Nennig ME, Shinefield HR, Edwards KM, et al: Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672-1674
22. Cromer BA, Goydos J, Hackell J, et al: Unrecognized pertussis infection in adolescents. Am J Dis Child 1993; 147:575-577
23. Addiss DG, Davis JP, Meade BD, et al: A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991; 164:704-710
24. Steketee RW, Wassilak SGF, Adkins WN, et al: Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988; 157:434-440
25. Tanaka Y, Fujinaga K, Goto A, et al: Outbreak of pertussis in a residential facility for handicapped people. Dev Biol Stand 1991; 73:329-332
26. Linneman CC, Ramundo N, Perlstein PH: Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975; 2:540-543
27. Kurt TL, Yeager AS, Suenette S, et al: Spread of pertussis staff by hospital staff. JAMA 1972; 221:264-267
28. Christie CDC, Glover AM, Willke MJ, et al: Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995; 16:556-563
29. Centers for Disease Control and Prevention: Pertussis outbreaks-Massachusetts and Maryland, 1992. MMWR 1993; 42:197-200
30. Wirsig von Konig CH, Postels-Multani S, Schmitt HJ: Pertussis in adults: frequency of transmission after household exposure. Lancet 1995; 346:1326-1329
31. Deen JL, Mink CM, Cherry JD, et al: Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211-1219
32. Postels-Multani S, Schmitt HJ, Wirsig von Konig CH, et al: Symptoms and complications of pertussis in adults. Infection 1995; 23:139-142
33. Schmitt-Grohe S, Cherry JD, Heininger U, et al: Pertussis in German adults. Clin Infect Dis 1995; 21:860-866
34. Halperin SA, Marrie TJ: Pertussis encephalopathy in an adult: case report and review. Rev Infect Dis 1991; 13:1043-1047
35. Colebunders R, Vael C, Blot K, et al: Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient. Eur J Clin Microbiol Infert Dis 1994; 13:313-315
36. Wright SW, Edwards KM, Decker MD, et al: Prevalence of positive serology for acute Chlamydia pneumoniae infection in adults with persistent cough. Acad Emerg Med 1997; 4:179-183
37. Centers for Disease Control and Prevention: Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46:25
38. Onorato IM, Wassilak SGF: Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J 1987; 6:145-151
39. Halperin SA, Bortolussi R, Langley JM, et al: Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 1997; 100:65-71
40. Hoppe JE, Eichhorn A: Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis 1989; 8:653-654
41. Hoppe JE, Halm U, Hagedorn HJ, et al: Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 1989; 17:227-231
42. Hoppe JE, Simon CG: In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. Antimicrob Agents Chemother 1990; 34:2287-2288
43. Hoppe JE, Muller J: In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins. Antimicrob Agents Chemother 1990; 34:1442-1443
44. Centers for Disease Control and Prevention: Erythromycinresistant Bordetella pertussis-Yuma County, Arizona, May-October 1994. MMWR 1994; 43:807-810
45. American Academy of Pediatrics: Pertussis. 1994 Red Book: Report of the Committee on Infectious Diseases. Peter G (ed). Elk Grove Village, I11, American Academy of Pediatrics, 23rd Ed, 1994, pp 355-367
46. Pichichero ME, Treanor J: Economic impact of pertussis. Arch Pediatr Adolesc Med 1997; 151:35-40
47. Edwards KM, Decker MD, Graham BS, et al: Adult immunization with acellular pertussis vaccine. JAMA 1993; 269:53-56
48. Davis SF, Sutter RW, Strebel PM, et al: Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis 1995; 20; 621-628